Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Clinical Trial to Assess the Performance of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis From Blood Samples of Subjects Who Are Either Pharmacotherapy-naive or Treatment-experienced and Their Physician Indicates Drug Therapy for Lyme Borreliosis

NCT03873974 is registered in ClinicalTrials.gov with Lyme Diagnostics Ltd. as lead sponsor.

NCT NCT03873974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Clinical Trial to Assess the Performance of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis From Blood Samples of Subjects Who Are Either Pharmacotherapy-naive or Treatment-experienced and Their Physician Indicates Drug Therapy for Lyme Borreliosis
Lead sponsor
Lyme Diagnostics Ltd.
Phase
Observational
Overall status
Completed
Start date
July 2, 2019
Completion date
December 4, 2019
Enrollment
400 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

lyme borreliosis